financetom
Business
financetom
/
Business
/
Tegna's Q1 Non-GAAP Net Income, Revenue Drops; Q2 Revenue Guidance Given
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tegna's Q1 Non-GAAP Net Income, Revenue Drops; Q2 Revenue Guidance Given
May 26, 2025 4:09 AM

08:49 AM EDT, 05/08/2025 (MT Newswires) -- Tegna ( TGNA ) reported Q1 non-GAAP net income Thursday of $0.37 per diluted share, down from $0.45 a year earlier.

Analysts polled by FactSet expected $0.32.

Revenue for the quarter ended March 31 was $680 million, down from $714.3 million a year earlier.

Analysts surveyed by FactSet expected $676.7 million.

The company said it expects Q2 revenue to decrease 4% to 7%. Analysts polled by FactSet expect $678.4 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
Mar 6, 2024
ViiV Healthcare, majority owned by GSK Plc ( GSK ) , with Pfizer Inc ( PFE ) and Shionogi Limited as shareholders, revealed data from a planned interim analysis of the LATITUDE phase 3 trial. The data indicated that long-acting injectable antiretroviral treatment (ART) for HIV, Cabenuva (cabotegravir + rilpivirine), demonstrated superior efficacy in maintaining viral load suppression compared to daily oral therapy in individuals with a history of...
--Hess Keeps Quarterly Dividend at $0.4375 Per Share; Payable March 28 to Shareholders of Record on March 18
--Hess Keeps Quarterly Dividend at $0.4375 Per Share; Payable March 28 to Shareholders of Record on March 18
Mar 6, 2024
04:42 PM EST, 03/06/2024 (MT Newswires) -- Price: 143.49, Change: +0.47, Percent Change: +0.33 ...
Procept Biorobotics Insider Sold Shares Worth $970,643, According to a Recent SEC Filing
Procept Biorobotics Insider Sold Shares Worth $970,643, According to a Recent SEC Filing
Mar 6, 2024
04:57 PM EST, 03/06/2024 (MT Newswires) -- Thomas M Krummel, Director, on March 04, 2024, sold 20,000 shares in Procept Biorobotics ( PRCT ) for $970,643. Following the Form 4 filing with the SEC, Krummel has control over a total of 65,631 shares of the company, with 65,631 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1588978/000162828024009436/xslF345X03/wk-form4_1709761831.xml ...
BRC Q4 Net Loss Narrows, Revenue Rises; Sets 2024 Revenue Outlook
BRC Q4 Net Loss Narrows, Revenue Rises; Sets 2024 Revenue Outlook
Mar 6, 2024
04:41 PM EST, 03/06/2024 (MT Newswires) -- BRC (BRCC) reported a Q4 net loss Wednesday of $0.07 per diluted share, narrowing from a loss of $0.09 a year earlier. Analysts polled by Capital IQ expected EPS of $0.01. Revenue for the quarter ended Dec. 31 was $119.7 million, up from $93.6 million a year earlier. Analysts surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved